Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 11.25%, which has investors questioning if this is right time to ...

That’s also around the time the Panacea merger is expected to close. There are also drugs targeting BET, WEE1 and A2A in preclinical development for leukaemia and solid tumours, and a series of ...